Back to search
Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: A report from children's cancer study group
Data up to Jan 2025
Published1984
Citations12
References5
Total Citations Per Year
Abstract
References (5)
Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.
1973 • 336 citations
Improved remission induction rate with D‐ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL
1979 • 55 citations
Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6‐thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy
1978 • 42 citations
Clinical pharmacology of O2,2'‐cyclocytidine
1975 • 17 citations
Phase I. evaluation of cyclocytidine (NSC-145668).
1975 • 10 citations
Cited By (0)
No citing papers found in database